A diabetic foot ulcer is a patient wound in the oldest sense of the word: it waits. Months of debridement, offloading, and dressing changes go by, and it sits open anyway, a quiet emergency that ends often enough in amputation, and sometimes in death. The standard of care treats such a wound the way a plumber treats a leak, something to be cleaned, covered, and coaxed shut. This month a team at the Shanghai University of Traditional Chinese Medicine published a survey of the literature arguing that the leak was never the problem. The immune system is.

The argument, led by first author Yi Ru, runs through eight immune cell types and lands hardest on the macrophage. In a wound that heals, macrophages arrive in an inflammatory posture to clear debris and bacteria, then switch to a reparative one that lays down tissue and builds new vessels. In a diabetic wound, the review says, they get stuck in the first job. Neutrophils spill their DNA into sticky traps that drag the inflammation out; regulatory T cells, which normally call the immune response off, fall in both number and function; dendritic cells stop clearing dead cells, so the debris piles up. The repair program stalls at the stage right before repair, and the cells sent to close the wound keep working it open.

The scale is not small, and the review is blunt about it. Roughly 131 million people worldwide live with chronic diabetic ulcers, at a cost of about $755 billion a year. A wound that will not close is, globally, one of the most expensive things medicine does badly.

THE BURDEN
131 million
people with chronic diabetic ulcers
$755 billion
in care costs a year
The global scale of a wound that will not close. Source: ScienceDaily – "Scientists may have found why diabetic wounds refuse to heal"

Which is why the framing around the paper rewards a careful read. It reached the public under the headline “Scientists may have found why diabetic wounds refuse to heal,” the kind of line that promises a discovery. A review does not discover; it gathers. The macrophage-polarization story it leans on, the tidy switch from inflammatory “M1” to reparative “M2,” has sat in the wound-healing literature for years, and the authors are candid that the model is contested, a useful cartoon more than a settled mechanism. They say so in print. What they have really done is assemble in one place what the field already suspected, and admit how much of it is still argument.

The paper’s second half reads like a biotech wish list: anti-cytokine biologics, drugs to nudge macrophages toward repair, stem cells and the vesicles they shed, engineered “smart” dressings, a class of redox-balancing enzymes. Almost none of it has been proven in a person with a diabetic ulcer. The clearest worked example sits outside the review entirely, at the Icahn School of Medicine at Mount Sinai, where Yizhou Dong’s group loaded a lipid nanoparticle with RNA encoding the cytokine IL-4 and used it to reprogram the stalled macrophages back toward their reparative state, reporting better healing in preclinical models in PNAS. The biology held up in the dish and the animal. It has not held up in a person, because no one has asked it to yet; the group’s own write-up calls for a rigorous randomized controlled trial to confirm safety and efficacy in humans.

For the patient whose ulcer is open this week, none of this changes the appointment. The dressing comes off, the dead tissue comes away, the pressure comes off the foot, the same as last month and the month before. What the review offers is a map of why that ritual fails so often, and a catalog of interventions that might one day make it unnecessary, not one of them yet proven where it would count.

Dong is the one asking, from New York, for the trial that would turn a decade of elegant immune biology into something a person with a wound could use. Until someone runs it, the immune system’s role in the diabetic wound is the best-mapped problem in the field, and still only a problem.

Sources

  1. Frontiers of Medicine – Ru et al., “Immune cells in diabetic wound repair: the key to better wound management” (review, 2026)
  2. ScienceDaily – “Scientists may have found why diabetic wounds refuse to heal”
  3. Icahn School of Medicine at Mount Sinai – Dong lab, IL-4 lipid-nanoparticle macrophage reprogramming for diabetic wounds (PNAS)